The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
The Epidemiology of Guillain-Barré Syndrome Worldwide
Abstract
Background: This systematic literature review of the epidemiology of Guillain-Barré syndrome (GBS) identifies trends in incidence rates by age, study method and cause of disease. It is important to have a reliable estimate of incidence to determine and investigate any changes: no previous systematic reviews of GBS have been found. Methods: After critical assessment of the reliability of the reported data, incidence rates were extracted from all relevant papers published between 1980 and 2008, identified through searches of Medline, Embase and Science Direct. Results: Sixty-three papers were included in this review; these studies were prospective, retrospective reviews of medical records or retrospective database studies. Ten studies reported on the incidence in children (0–15 years old), and found the annual incidence to be between 0.34 and 1.34/100,000. Most studies investigated populations in Europe and North America and reported similar annual incidence rates, i.e. between 0.84 and 1.91/100,000. A decrease in incidence over the time between the 1980s and 1990s was found. Up to 70% of cases of GBS were caused by antecedent infections. Conclusions: Our best estimate of the overall incidence of GBS was between 1.1/100,000/year and 1.8/100,000/year. The incidence of GBS increased with age after 50 years from 1.7/100,000/year to 3.3/100,000/year.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hughes, R. A., & Cornblath, D. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67665-9 · Cited by 1,676
MacDonald, B. K. (2000) · Brain · doi:10.1093/brain/123.4.665 · Cited by 858
Campylobacter Species and Guillain-Barré Syndrome
Nachamkin, I., Allos, B. M., & Ho, T. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.555 · Cited by 590
Clinical and Epidemiologic Features of Guillain‐Barré Syndrome
Hughes, R. A. C., & Rees, J. H. (1997) · The Journal of Infectious Diseases · doi:10.1086/513793 · Cited by 456
Epidemiological study of Guillain-Barre syndrome in south east England
Rees, J. H., Thompson, R. D., Smeeton, N. C., & Hughes, R. A. C. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.1.74 · Cited by 258
Guillain–Barré syndrome: Incidence and mortality rates in US hospitals
Alshekhlee, A., Hussain, Z., Sultan, B., & Katirji, B. (2008) · Neurology · doi:10.1212/01.wnl.0000310983.38724.d4 · Cited by 211
Mild forms of Guillain-Barré syndrome in an epidemiologic survey in the Netherlands
Van Koningsveld, R., Van Doorn, P. A., Schmitz, P. I. M., Ang, C. W., & Van der Meché, F. G. A. (2000) · Neurology · doi:10.1212/wnl.54.3.620 · Cited by 170
Epidemiology of the Guillain-Barré syndrome
Govoni, V., & Granieri, E. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200110000-00009 · Cited by 143
No Association Between Immunization and Guillain-Barré Syndrome in the United Kingdom, 1992 to 2000
Hughes, R. A., Charlton, J., Latinovic, R., & Gulliford, M. C. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.12.1301 · Cited by 100
Bogliun, G., Beghi, E., & the Italian GBS Registry Study Group* (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00272.x · Cited by 95
Cited by
Cost of disorders of the brain in Europe 2010
Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.08.008 · Cited by 1,723
Kirk, M. D., Pires, S. M., Black, R. E., Caipo, M., Crump, J. A., Devleesschauwer, B., Döpfer, D., Fazil, A., Fischer-Walker, C. L., Hald, T., et al. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001921 · Cited by 1,625
“We considered that 31% of Guillain-Barré Syndrome (GBS) cases globally were associated with antecedent Campylobacter infection and that the CFR for GBS was 4.1% [38,39].”
InfluentialPopulation Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis
Sejvar, J. J., Baughman, A. L., Wise, M., & Morgan, O. W. (2011) · Neuroepidemiology · doi:10.1159/000324710 · Cited by 960
Shahrizaila, N., Lehmann, H. C., & Kuwabara, S. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00517-1 · Cited by 697
McElhaney, J. E., Beran, J., Devaster, J.-M., Esen, M., Launay, O., Leroux-Roels, G., Ruiz-Palacios, G. M., van Essen, G. A., Caplanusi, A., Claeys, C., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70046-x · Cited by 164
Metadata
- Authors
- McGrogan, A., Madle, G. C., Seaman, H. E., & de Vries, C. S.
- Venue
- Neuroepidemiology
- Publisher
- S. Karger AG
- Published
- 2008-12-17
- Volume
- 32
- Issue
- 2
- Pages
- 150-163
- ISSN
- 0251-5350 (ISSN-L)
- 1423-0208
- OpenAlex
- W2080582088
- Cited by
- 573
- References
- 19
- FWCI
- 8.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Epidemiology of Guillain-Barré Syndrome Worldwide. https://app.cochat.ai/papers/10.1159/000184748
- The paper
- McGrogan, A., Madle, G. C., Seaman, H. E., & de Vries, C. S. (2009). The Epidemiology of Guillain-Barré Syndrome Worldwide. Neuroepidemiology. https://doi.org/10.1159/000184748
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.